Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» major depressive disorder
major depressive disorder
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail
Fierce Biotech
Tue, 04/23/24 - 09:42 pm
Neurocrine Biosciences
clinical trials
Takeda
major depressive disorder
Savitri
Intra-Cellular Launches 26% To Record High, Breaking Out After Depression Drug Scores Big
Investors Business Daily
Tue, 04/16/24 - 11:13 am
Intra-Cellular Therapies
Caplyta
clinical trials
major depressive disorder
Cybin CEO on FDA breakthrough designation for psychedelic drug treating MDD
Medical Marketing and Media
Mon, 04/1/24 - 11:48 am
Cybin
FDA
psychedelics
major depressive disorder
MindBio nears completion of MB22001 trial for depression
Clinical Trials Arena
Wed, 01/31/24 - 11:46 am
MindBio Therapeutics
clinical trials
LSD
MB22001
major depressive disorder
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
As J&J outlines bullish pipeline goals, neuroscience pipeline takes a starring role
Fierce Biotech
Wed, 12/6/23 - 09:15 pm
JNJ
Neuroscience
Spravato
major depressive disorder
Alto’s Neuropsychiatric Platform Scores Third Mid-Stage Win
BioSpace
Tue, 12/5/23 - 09:55 am
Alto Neuroscience
ALTO-300
major depressive disorder
clinical trials
Xenon Looks to Raise Cash for MDD Program with $300M Public Offering
BioSpace
Thu, 11/30/23 - 11:15 pm
Xenon
major depressive disorder
stock offering
Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry
BioSpace
Fri, 11/10/23 - 10:14 am
Neurocrine
neuropsychiatric
clinical trials
focal onset seizures
major depressive disorder
NBI-921352
NBI-1065846
Novartis cuts depression study, nearly erasing $210M Cadent acquisition from pipeline
Fierce Biotech
Tue, 10/10/23 - 11:36 am
Novartis
Cadent Therapeutics
major depressive disorder
MIJ821
Exxua Charts a New Path in Depression Treatment Following FDA Nod
Xtalks
Thu, 09/28/23 - 11:38 pm
Fabre-Kramer Pharmaceuticals
FDA
Exxua
major depressive disorder
depression
Biomed reports data from trial of MDD therapy
Clinical Trials Arena
Wed, 08/16/23 - 09:58 am
BioMed
NA-831
major depressive disorder
clinical trials
Biogen, Sage's postpartum depression approval overshadowed by larger rejection
Fierce Pharma
Mon, 08/7/23 - 12:01 pm
SAGE Therapeutics
Biogen
FDA
Zurzuvae
postpartum depression
major depressive disorder
FDA Approves Biogen, Sage’s Zurzuvae as First Pill for Postpartum Depression
BioSpace
Sun, 08/6/23 - 09:39 pm
Biogen
SAGE Therapeutics
FDA
Zurzuvae
postpartum depression
major depressive disorder
zuranolone
FDA Action Alert: Mesoblast, Sage/Biogen and Galera
BioSpace
Mon, 07/31/23 - 10:05 am
FDA
graft vs host disease
head and neck cancer
postpartum depression
major depressive disorder
Mesoblast
remestemcel-L
Biogen
SAGE Therapeutics
zuranolone
Galera Therapeutics
avasopasem manganese
Go or no go? Biogen and Astellas head towards key PDUFAs
EP Vantage
Sat, 07/29/23 - 10:45 pm
FDA
Astellas
Zimura
Biogen
SAGE Therapeutics
zuranolone
major depressive disorder
postpartum depression
geographic atrophy
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
MindMed Collaborators Announce Positive Phase II Results for LSD in Major Depressive Disorder
Genetic Engineering News
Fri, 04/14/23 - 10:09 am
MindMed
clinical trials
lysergide
LSD
major depressive disorder
Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Clinical Trials Arena
Wed, 03/29/23 - 09:40 am
Intra-Cellular Therapies
clinical trials
Caplyta
major depressive disorder
bipolar disorder
Relmada Looks to Rebound with New Protocol After Two Phase III Flops
BioSpace
Mon, 03/27/23 - 10:05 am
Relmada Therapeutics
REL-1017
major depressive disorder
Pages
1
2
3
4
5
next ›
last »